Sjogren's Disease Clinical Trial
— ETREINTEOfficial title:
Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease : Etude ETREINTE.
This aim of this study is to compare the reproducibility of reading of five international
experts concerning the anomalies of the salivary glands.
The reproducibility is measure on patients and not on recorded data.
Status | Completed |
Enrollment | 21 |
Est. completion date | March 2015 |
Est. primary completion date | March 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Men and women from 18 to 80 years old - Patients recruited during the multidisciplinary consultation of Sjogren's Disease, filling the criteria of Sjogren's Disease or patients having a salivary recidivate pathology and selected players on the basis of their voluntary service to benefit from an ultrasound of the main salivary glands - The patients will have to be capable of adhering to the protocol of study and of having understood it. - The patients will have to be capable of giving a signed informed consent, the latter being obtained before the inclusion Exclusion Criteria: - Not cooperative patient and having refused to sign the informed consent. - Patient incapable to understand the protocol, under guardianship or under guardianship. - Unaffiliated patients to the Social Security. |
Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator)
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reproducibility between experts | The outcome measure will be assessed bythe answer of a questionnaire which will be complete by the 5 international experts. | 1 day | No |
Secondary | Reproducibility by the sonographer | The sonographer's reproductibility will be assesses by the answer of a questionnaire which will be complete by the 5 international experts. | 1 day | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02148497 -
Multi-Colored Placido Disk Viability
|
N/A | |
Completed |
NCT00740948 -
Tolerance and Efficacy of Rituximab in Sjogren's Disease
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06392711 -
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
|
Phase 1 | |
Completed |
NCT01234623 -
Cord Blood Serum in the Treatment of Ocular Surface Diseases
|
Phase 1 | |
Completed |
NCT02322528 -
Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax
|
N/A |